Last 48 quarters of trend data · Healthcare · Healthcare Providers
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -3.01 | 18.09 | 61.52 | 129.37 | — | 15.47 | 17.19 | 84.22 | 28.32 | 21.42 | 19.86 | 23.86 | 30.86 | — | 25.20 | 25.09 | 30.72 | 25.06 | 19.21 | 24.45 | 19.71 |
| — | +16.9% | +257.9% | +53.6% | — | -27.8% | -13.5% | +253.0% | -8.2% | — | -21.2% | -4.9% | +0.5% | — | +31.2% | +2.6% | +55.9% | +14.7% | -40.0% | -81.2% | — | |
| P/S Ratio | 1.01 | 0.70 | 0.78 | 0.64 | 0.39 | 0.66 | 0.59 | 0.91 | 1.18 | 1.79 | 1.95 | 2.37 | 2.40 | 2.14 | 2.49 | 2.34 | 2.80 | 2.69 | 2.37 | 2.42 | 2.33 |
| — | +7.0% | +32.0% | -29.2% | -66.8% | -63.3% | -69.8% | -61.8% | -51.0% | -16.1% | -21.7% | +1.2% | -14.1% | -20.6% | +5.0% | -3.1% | +20.3% | +9.0% | -2.8% | +3.7% | +12.4% | |
| P/B Ratio | 1.57 | 1.12 | 1.23 | 0.98 | 0.60 | 0.68 | 0.64 | 0.88 | 1.14 | 1.86 | 2.03 | 2.45 | 2.47 | 2.28 | 2.42 | 2.25 | 2.61 | 2.53 | 2.26 | 2.25 | 2.14 |
| — | +64.3% | +93.4% | +11.5% | -47.5% | -63.3% | -68.6% | -64.1% | -53.8% | -18.5% | -16.2% | +8.7% | -5.1% | -9.9% | +7.2% | -0.1% | +21.9% | +6.3% | -6.4% | +0.8% | -9.4% | |
| P/FCF | 37.75 | 13.38 | 2.83 | — | — | — | — | — | — | — | 91.93 | — | — | 163.40 | 24.99 | — | 72.20 | — | 22.99 | 56.78 | 143.03 |
| — | — | — | — | — | — | — | — | — | — | +267.9% | — | — | — | +8.7% | — | -49.5% | — | -41.4% | -23.3% | +2014.8% | |
| EV / EBITDA | 11.15 | 7.27 | 9.21 | 8.51 | 10.18 | 6.81 | 5.63 | 20.77 | 9.89 | 10.51 | 11.35 | 13.92 | 13.33 | 11.66 | 7.38 | 7.61 | 8.59 | 8.09 | 7.18 | 7.83 | 7.54 |
| — | +6.7% | +63.7% | -59.0% | +3.0% | -35.2% | -50.4% | +49.3% | -25.8% | -9.8% | +53.7% | +82.8% | +55.2% | +44.1% | +2.8% | -2.8% | +13.9% | -39.8% | -6.2% | -0.5% | -16.6% | |
| EV / EBIT | 15.38 | 12.97 | 10.11 | 23.52 | — | 14.85 | 12.64 | 29.47 | 20.77 | 15.13 | 14.96 | 18.24 | 21.29 | — | 16.12 | 18.07 | 20.89 | 18.22 | 15.64 | 18.89 | 18.07 |
| — | -12.7% | -20.1% | -20.2% | — | -1.8% | -15.5% | +61.5% | -2.5% | — | -7.2% | +1.0% | +1.9% | — | +3.1% | -4.3% | +15.6% | +3.1% | -6.0% | +0.4% | -7.9% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 17.6% | 19.3% | 16.6% | 16.5% | 11.7% | 96.4% | 96.7% | 32.6% | 96.3% | 96.4% | 24.0% | 22.7% | 23.0% | 24.0% | 43.6% | 40.8% | 42.0% | 43.3% | 44.1% | 41.7% | 42.0% |
| — | -80.0% | -82.9% | -49.3% | -87.9% | +0.1% | +303.6% | +43.4% | +319.4% | +302.0% | -45.0% | -44.2% | -45.3% | -44.6% | -1.2% | -2.3% | -0.0% | -0.2% | +2.5% | +1.9% | +4.6% | |
| Operating Margin | 11.7% | 12.7% | 10.1% | 10.1% | 5.8% | 14.0% | 16.4% | 1.7% | 13.4% | 18.0% | 17.9% | 16.8% | 16.8% | 17.9% | 36.0% | 33.3% | 34.3% | 35.5% | 36.2% | 33.9% | 34.5% |
| — | -9.2% | -38.1% | +478.7% | -56.6% | -22.2% | -8.7% | -89.6% | -20.6% | +0.8% | -50.2% | -49.6% | -50.9% | -49.6% | -0.5% | -1.8% | -0.5% | +98.6% | +2.2% | +1.3% | +4.6% | |
| Net Margin | -33.3% | 3.9% | 1.3% | 0.5% | -143.3% | 4.3% | 3.5% | 1.1% | 4.2% | 8.4% | 9.9% | 9.9% | 7.8% | -29.0% | 9.9% | 9.4% | 9.1% | 10.7% | 12.3% | 9.9% | 11.8% |
| — | -9.5% | -63.6% | -54.4% | -3502.8% | -49.0% | -64.8% | -89.1% | -45.8% | +128.8% | -0.3% | +6.1% | -14.1% | -372.1% | -19.5% | -5.0% | -23.6% | -5.2% | +60.7% | +459.6% | +108.2% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -41.4% | 1.6% | 0.5% | 0.2% | -43.4% | 1.1% | 0.9% | 0.3% | 1.0% | 2.2% | 2.6% | 2.6% | 2.0% | -7.5% | 2.4% | 2.3% | 2.1% | 2.6% | 3.0% | 2.3% | 2.8% |
| — | +39.4% | -46.8% | -27.6% | -4312.8% | -49.3% | -63.8% | -89.9% | -49.2% | +129.3% | +6.8% | +15.1% | -5.0% | -393.0% | -18.2% | -2.7% | -23.9% | -7.5% | +55.5% | +402.7% | +108.1% | |
| ROA | -19.2% | 0.6% | 0.2% | 0.1% | -19.7% | 0.6% | 0.5% | 0.1% | 0.6% | 1.2% | 1.4% | 1.4% | 1.1% | -4.1% | 1.4% | 1.3% | 1.2% | 1.4% | 1.6% | 1.3% | 1.5% |
| — | +9.0% | -59.3% | -46.5% | -3676.4% | -51.7% | -65.5% | -90.1% | -48.9% | +128.4% | -1.1% | +6.7% | -12.4% | -386.6% | -13.9% | +3.9% | -18.0% | +0.2% | +68.3% | +618.7% | +113.0% | |
| ROIC | 5.9% | 1.9% | 1.4% | 1.3% | 0.7% | 1.6% | 2.0% | 0.2% | 1.5% | 2.2% | 2.2% | 2.1% | 2.2% | 2.3% | 4.5% | 4.0% | 4.0% | 4.2% | 4.3% | 3.8% | 3.9% |
| — | +15.2% | -27.5% | +607.0% | -53.9% | -26.4% | -9.8% | -91.0% | -31.4% | -5.5% | -51.2% | -47.6% | -45.4% | -44.7% | +4.5% | +5.3% | +3.3% | +101.4% | +3.7% | +17.5% | +56.1% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.24 | 1.11 | 1.17 | 1.23 | 1.24 | 0.74 | 0.74 | 0.73 | 0.65 | 0.64 | 0.64 | 0.67 | 0.52 | 0.54 | 0.51 | 0.53 | 0.53 | 0.55 | 0.57 | 0.62 | 0.63 |
| — | +50.7% | +58.1% | +67.9% | +89.8% | +15.5% | +14.9% | +9.8% | +24.9% | +19.0% | +26.4% | +25.2% | -0.8% | -1.6% | -10.0% | -13.5% | -16.9% | -13.8% | -16.4% | -13.0% | -63.0% | |
| Debt / EBITDA | 4.60 | 14.97 | 18.55 | 19.59 | 28.43 | 14.53 | 12.47 | 38.48 | 14.58 | 10.88 | 11.04 | 12.02 | 9.42 | 8.99 | 5.20 | 5.87 | 5.84 | 5.80 | 5.86 | 6.86 | 7.03 |
| — | +3.0% | +48.8% | -49.1% | +94.9% | +33.6% | +13.0% | +220.0% | +54.8% | +20.9% | +112.3% | +104.7% | +61.2% | +55.1% | -11.2% | -14.3% | -16.9% | -50.0% | -15.1% | -11.9% | -56.1% | |
| Current Ratio | 1.55 | 1.60 | 1.57 | 1.71 | 1.55 | 1.44 | 1.32 | 1.35 | 1.00 | 1.07 | 1.18 | 1.27 | 0.67 | 0.81 | 1.34 | 1.42 | 1.30 | 1.30 | 1.17 | 1.29 | 1.22 |
| — | +10.5% | +19.1% | +26.7% | +55.1% | +35.0% | +11.9% | +6.6% | +48.5% | +31.5% | -11.8% | -11.0% | -48.4% | -37.5% | +14.1% | +10.2% | +6.6% | -7.5% | -13.4% | +0.4% | -36.6% | |
| Quick Ratio | 1.54 | 1.59 | 1.56 | 1.70 | 1.54 | 1.43 | 1.31 | 1.34 | 0.99 | 1.06 | 1.17 | 1.25 | 0.67 | 0.81 | 1.33 | 1.41 | 1.29 | 1.29 | 1.16 | 1.28 | 1.21 |
| — | +10.7% | +19.2% | +27.0% | +55.6% | +35.0% | +11.9% | +6.6% | +48.4% | +31.4% | -11.8% | -10.9% | -48.3% | -37.4% | +14.1% | +10.1% | +6.6% | -7.7% | -13.5% | +0.4% | -37.1% | |
| Interest Coverage | -6.68 | 2.51 | 3.30 | 1.29 | -29.83 | 2.09 | 2.42 | 1.46 | 2.26 | 4.29 | 4.65 | 4.63 | 4.91 | -12.86 | 6.46 | 5.61 | 5.55 | 6.57 | 7.34 | 6.25 | 6.25 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying ACHC stock.
Acadia Healthcare Company, Inc.'s current P/E is -3.0x. The average P/E over the last 3 quarters is 69.7x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Acadia Healthcare Company, Inc.'s current operating margin is 11.7%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Acadia Healthcare Company, Inc.'s business trajectory between earnings reports.